Investigating hepatitis E virus seroprevalence in patients with Alzheimer's disease.

Front Aging Neurosci · 2026 · PMC13190613 · PMID 42182563

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep = 0.080so close (0.05 < p ≤ 0.1)

Age-stratified seroprevalence analysis In the subgroup analysis, HEV IgG seroprevalence was higher in the AD group than in the non-AD group in the 60–69-year age group but this difference did not reach statistical significance in a conventional two-sided comparison ( Supplementary Figure S3 , 46.5% vs. 35.1%; two-sided p = 0.080).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.